You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CYTK Exercise Disclosure
Callos Andrew · SEC Form 4 · Filed Jun 1, 2026
Exercise
Calculated transaction value
$348.9K
Callos Andrew EVP, Chief Commercial Officer
CYTK
Cytokinetics Inc
CYTK
Transaction date
Jun 1, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed same day
CYTK daily price context
Close on/before transaction
$73.68
Jun 1, 2026
First close after public filing
$70.91
Jun 2, 2026
30-day return after filing
+20.24%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 15,000 shares @ $23.26
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001061983-26-000065
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.46M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK Current | Exercise | Jun 1, 2026 | $348.9K |
| Cytokinetics Inc CYTK | Sale | Jun 1, 2026 | $1.11M |
| Cytokinetics Inc CYTK | Exercise | Jun 1, 2026 | $0 |